PHI with Neurodermatitis (ongoing treatment)
How does this condition affect your private health insurance?
Neurodermitis, or atopic dermatitis, is a chronic inflammatory skin condition characterized by dry, itchy, and red skin patches. It typically begins in infancy or childhood, though it can manifest at any age. The condition results from a genetic predisposition combined with environmental triggers, leading to a compromised skin barrier and an exaggerated immune response. Intense itching is a hallmark symptom, often leading to scratching that further damages the skin and increases susceptibility to secondary infections. It's a relapsing-remitting condition requiring ongoing management to control symptoms and prevent complications, significantly impacting patients' quality of life.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to several weeks for a flare-up
Duration of Illness (Lifetime)
Chronic, often lifelong with fluctuating severity
Cost of Treatment (Initial)
Moderate (e.g., 100-500 EUR for initial diagnosis and topical treatment, higher for severe cases)
Cost of Treatment (Lifetime)
High (thousands to tens of thousands EUR over a lifetime due to continuous medication, specialized care, and flare-up management)
Mortality Rate
Extremely low, not a direct cause of death
Risk of Secondary Damages
High (e.g., bacterial/viral skin infections, psychological distress like anxiety/depression, sleep disturbances, scarring)
Probability of Full Recovery
Low (spontaneous complete remission is rare, but long-term symptom control is achievable)
Underlying Disease Risk
High (commonly co-occurs with other atopic conditions like asthma, allergic rhinitis, and food allergies)